Did MRI Appearance of Supraspinatus Muscle Atrophy Changes After Repair of All Kind of Rotator Cuff Tear?
NCT ID: NCT02628457
Last Updated: 2015-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
209 participants
OBSERVATIONAL
2015-12-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mild Subgroup
patients with supraspinatus tendon retracted upto medial 1/3rd of humerus head and arthroscopic rotator cuff repair done by single row.
arthroscopic rotator cuff repair
arthroscopic rotator cuff repair done in all patients to check whether, surgery itself changes the appearance of muscle atrophy in the supraspinatus in all patients irrespective of size of preoperative tendon retraction
Moderate Subgroup
patients with supraspinatus tendon retracted between medial 1/3rd of humerus head and glenoid,and arthroscopic rotator cuff repair done by single row.
arthroscopic rotator cuff repair
arthroscopic rotator cuff repair done in all patients to check whether, surgery itself changes the appearance of muscle atrophy in the supraspinatus in all patients irrespective of size of preoperative tendon retraction
Severe subgroup
patients with supraspinatus tendon retracted beyond glenoid and arthroscopic rotator cuff repair done by single row
arthroscopic rotator cuff repair
arthroscopic rotator cuff repair done in all patients to check whether, surgery itself changes the appearance of muscle atrophy in the supraspinatus in all patients irrespective of size of preoperative tendon retraction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
arthroscopic rotator cuff repair
arthroscopic rotator cuff repair done in all patients to check whether, surgery itself changes the appearance of muscle atrophy in the supraspinatus in all patients irrespective of size of preoperative tendon retraction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with preoperative MRI and postoperative MRI within 1 week of surgery in our hospital.
3. Patients with minimum grade 1 supraspinatus atrophy in preoperative MRI.
Exclusion Criteria
2. Patients with isolated subscapularis tear.
3. Patients with previous operation on the same shoulder joint.
4. Patients with MRI images that were not usable due to poor quality or absence of appropriate Y-view.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CM Chungmu Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
sang-Hoon Lhee, MD PhD
Role: STUDY_CHAIR
President, CM general Hospital
Anant kumar Singh
Role: PRINCIPAL_INVESTIGATOR
arthroscopy fellow, CM general Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chungmu General Hopsital
Yeongdeungpo-gu, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMH-2015-02
Identifier Type: -
Identifier Source: org_study_id